L. O. Henriksen

Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsis

A. Haase, D. van de Kerkhof, A. Münster, 2018, Scandinavian journal of clinical and laboratory investigation.

Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration.

S. Kristensen, S. Husted, M. D. de Maat, 2018, Thrombosis research.

Measurement of dabigatran: previously demonstrated Hemoclot® Thrombin Inhibitor assay reagent instability on Sysmex CS-2100i is no longer an issue

A. Münster, W. Comuth, L. O. Henriksen, 2018, Scandinavian journal of clinical and laboratory investigation.

Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21°C

E. Nexo, A. B. Hansen, L. O. Henriksen, 2014, Scandinavian journal of clinical and laboratory investigation.

Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.

T. Jensen, K. Kragballe, H. Sølvsten, 1998, Biochemical pharmacology.

EXPRESSION AND POST‐TRANSLATIONAL MODIFICATION OF HUMAN 4‐HYDROXY‐PHENYLPYRUVATE DIOXYGENASE

K. Kristiansen, H. Leffers, N. Tommerup, 2002, Cell biology international.